Skip to main content
Year archive

IMPEDIMED LIMITED — 2018 filings

All 56 regulatory filings released by IMPEDIMED LIMITED (IPD) in 2018, sourced directly from the official regulator.

56 Filings
2018 Period
2018 filings (56)
Filing Released Lang
L-Dex Early Surveillance Reduces Incidence, Severity & Cost 2 pages 91.3KB
Regulatory Filings
2018-12-09 English
Bioimpedance & L-Dex Recommendation in Leading Journals 2 pages 99.3KB
Regulatory Filings
2018-11-18 English
Chairman's Address 2 pages 265.2KB
AGM Information
2018-10-16 English
Annual General Meeting Presentation 27 pages 9.0MB
Investor Presentation
2018-10-16 English
Results of Meeting 1 page 61.1KB
Declaration of Voting Results & Voting Rights Announcements
2018-10-16 English
Health Plan Adopts SOZO for Monitoring CHF Patients 2 pages 247.6KB
Regulatory Filings
2018-10-15 English
Appendix 4C - Quarter ended 30 September 2018 7 pages 411.8KB
Interim / Quarterly Report
2018-10-15 English
ImpediMed Completes Asset Sale of XiTRON Technologies, Inc. 1
Capital/Financing Update
2018-10-11 English
First Patient Enrolled in 200 Patient Heart Failure Trial 2 pages 251.3KB
Regulatory Filings
2018-10-09 English
Notice of Annual General Meeting & Proxy Form 21 pages 423.7KB
AGM Information
2018-09-16 English
SOZO Abstract Presentations at Key Cardiology Meetings 2 pages 254.9KB
Regulatory Filings
2018-09-10 English
Ceasing to be a substantial holder from MUFG 7 pages 210.1KB
Regulatory Filings
2018-08-30 English
Appendix 4E 5 pages 241.3KB
Regulatory Filings
2018-08-29 English
Annual Report 30 June 2018 73 pages 15.0MB
Regulatory Filings
2018-08-29 English
Appendix 4G and Corporate Governance Statement 28 pages 2.0MB
Governance Information
2018-08-29 English
Ceasing to be a substantial holder from MS 10 pages 365.5KB
Regulatory Filings
2018-08-29 English
Becoming a substantial holder from MUFG 24 pages 1.0MB
Regulatory Filings
2018-08-28 English
Becoming a substantial holder from MS 24 pages 1.5MB
Regulatory Filings
2018-08-27 English
L-Dex Suggested as a New Standard of Care 2 pages 240.2KB
Regulatory Filings
2018-08-23 English
Response to ASX Aware Query 5 pages 475.0KB
Regulatory Filings
2018-08-23 English
PREVENT Trial Results Published - Outstanding Initial Data 2 pages 236.3KB
Regulatory Filings
2018-08-22 English
Ceasing to be a substantial holder from MUFG 8 pages 299.9KB
Regulatory Filings
2018-08-14 English
Ceasing to be a substantial holder from MS 12 pages 456.2KB
Regulatory Filings
2018-08-13 English
Change in substantial holding from MQG 60 pages 692.8KB
Major Shareholding Notification
2018-08-12 English
Becoming a substantial holder from MUFG 30 pages 1.1MB
Regulatory Filings
2018-08-09 English
Becoming a substantial holder from MS 24 pages 1.6MB
Regulatory Filings
2018-08-08 English
ImpediMed to present at Canaccord Growth Conference in USA 29 pages 12.4MB
Investor Presentation
2018-08-06 English
Appendix 3B 13 pages 153.0KB
Share Issue/Capital Change
2018-07-30 English
Ceasing to be a substantial holder from MUFG 5 pages 193.3KB
Regulatory Filings
2018-07-29 English
Becoming a substantial holder from MUFG 25 pages 994.7KB
Regulatory Filings
2018-07-26 English
Ceasing to be a substantial holder from MS 10 pages 342.7KB
Regulatory Filings
2018-07-26 English
Becoming a substantial holder from MS 22 pages 1.4MB
Regulatory Filings
2018-07-25 English
Appendix 4C - Quarter ended 30 June 2018 7 pages 423.2KB
Interim / Quarterly Report
2018-07-22 English
Investor Presentation 28 pages 12.1MB
Investor Presentation
2018-07-22 English
ImpediMed Quarterly Results and Investor Conference Call 1
Call Transcript
2018-07-19 English
Becoming a substantial holder from MQG 19 pages 535.0KB
Major Shareholding Notification
2018-07-02 English
Ceasing to be a substantial holder from MQG 18 pages 529.1KB
Major Shareholding Notification
2018-06-28 English
Becoming a substantial holder from MQG 57 pages 713.3KB
Major Shareholding Notification
2018-06-27 English
SOZO Presentation at World Congress on Heart Disease 1
Regulatory Filings
2018-06-19 English
Change of Director's Interest Notice 4 pages 281.6KB
Director's Dealing
2018-06-11 English
Appendix 3B 12 pages 112.0KB
Capital/Financing Update
2018-06-04 English
Notification under section 708A(5)(e) 2 pages 27.3KB
Share Issue/Capital Change
2018-06-04 English
Change of Director's Interest Notice 2 pages 64.0KB
Director's Dealing
2018-05-29 English
Assessment with L-Dex Features at ALA 2 pages 137.9KB
Regulatory Filings
2018-05-22 English
L-Dex Featured at American Society of Breast Surgeons 2 pages 53.2KB
Regulatory Filings
2018-05-09 English
Appendix 3B 13 pages 148.0KB
Share Issue/Capital Change
2018-04-30 English
Notification under section 708A(5)(e) 2 pages 49.4KB
Share Issue/Capital Change
2018-04-30 English
Appendix 4C - Quarter ended 31 March 2018 7 pages 306.6KB
Interim / Quarterly Report
2018-04-25 English
ImpediMed Quarterly Results & Investor Conference Call 1
Investor Presentation
2018-04-23 English
Interim Results of PREVENT Trial 2 pages 58.1KB
Earnings Release
2018-04-18 English
US FDA 510(k) Clearance for Bilateral Lymphoedema Assessment 2 pages 72.4KB
Regulatory Filings
2018-04-16 English
ImpediMed & Sharp HealthCare Sign Agreement for SOZO 2 pages 54.6KB
Capital/Financing Update
2018-03-06 English
Appendix 4D and Interim Financial Report 35 pages 5.1MB
Regulatory Filings
2018-02-21 English
Change in substantial holding 2 pages 97.6KB
Regulatory Filings
2018-02-13 English
Appendix 4C - Quarter ended 31 December 2017 8 pages 431.9KB
Interim / Quarterly Report
2018-01-29 English
Quarterly Results and Investor Conference Call Notification 1
Regulatory Filings
2018-01-28 English